Establishes a National Biopharmaceutical Manufacturing Center of Excellence to advance biopharmaceutical manufacturing.
The Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence. The Center aims to advance biopharmaceutical manufacturing by developing new technologies, improving manufacturing processes, and supporting workforce training. It will collaborate with higher education institutions, pharmaceutical manufacturers, and government agencies. The Center will also create intellectual property guidelines and share best practices. The Director will award a grant to an eligible entity to establish and operate the Center.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.